Foster Corporation Appointed Marketing Partner for Röhm’s CYROLITE® Portfolio of PMMA-Based (Acrylic) Medical Grade Products for the North American Healthcare Market
Putnam, CT – (February 21, 2023) – Foster Corporation’s Distribution business, a leader in material solutions for the “critical application” healthcare market segment, has been appointed as a marketing partner for Röhm’s CYROLITE®, CYROLITE® MD and XT® Polymer portfolio of advanced medical acrylic-based polymers for the North American healthcare market. Foster Distribution will provide sales, technical support, and order fulfillment support from its locations in Connecticut and Nevada.
Röhm’s medical grade CYROLITE® brand is one of the most complete and durable lines of acrylic based technologies in the medical material segment and has been in production for more than 50 years. Over its history, the Röhm portfolio has proven to be a reliable and trustworthy resource for applications where transparency, toughness, chemical resistance (alcohol and lipid resistance), gamma/EtO sterilization, and processability are key specification criteria. In addition, every product in Röhm’s extensive healthcare product portfolio are biotested to USP Class VI and ISO 10993.
“CYROLITE® products have been a mainstay material in the medical device industry for many years”, says Larry Johnson, President, Foster Distribution. “Its clarity is unsurpassed and its balanced property matrix makes it a go-to material for many medical device applications that require high-performance at a value-based price point. We couldn’t be more pleased to welcome Röhm into our partnership family. Their product line has more than proven itself over the years and they know the medical industry and its needs and strive to meet those needs” he continues.
“We’re excited to partner with the Foster team which will provide improved distribution of Röhm’s CYROLITE® brand to our customers in key medical application segments”, says Thomas Hemler, Global Segment Director, Medical Molding Compounds, Röhm. “Our CYROLITE® product applications range from blood and IV filter housings, fluid connectors, IVD & microfluidic chips – to orthopedic trays and combination devices for medical device disposables, diagnostics, drug delivery, respiratory & anesthesiology, and medical packaging.”
For more information about Foster Distribution’s full suite of medical-grade polymers and solutions, please contact our Foster Sales Team on our website at www.fosterpolymers.com.
About Foster Corporation
For over thirty years Foster Corporation has been serving medical device manufacturers with industry leading technology and service in biomedical materials. These include custom medical compounds, implantable materials, and polymer distribution. Within ISO 13485:2016 facilities, Foster offers comprehensive support to customers from formulation development through production.
With 3,500 employees and 13 production sites worldwide, Röhm is one of the leading manufacturers in the methacrylate business. The medium-sized company with branches in Germany, China, the USA, Mexico, and South Africa has more than 80 years of experience in methacrylate chemistry and a strong technology platform. Our best-known brands include PLEXIGLAS®, ACRYLITE®, MERACRYL®, DEGALAN®, DEGAROUTE® and CYROLITE®.
Polymethyl methacrylate (PMMA) products from Röhm are sold on the European, Asian, African and Australian continent under the registered trademarks PLEXIGLAS® and PLEXIMID®, in the Americas under the registered trademarks ACRYLITE® and ACRYMID®.